Live from the NIH registry
Studies recruiting near Tucson right now
Top 25 of 475 recruiting studies, sorted by proximity — each links to its official registry page
Lupus Landmark Study: A Prospective Registry and Biorepository
Systemic Lupus Erythematosus (SLE), Lupus Nephritis
N/A
Observational 3,500 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: Lupus Research Alliance
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Center for Neurosciences — Tucson, Arizona (5.4 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: Novartis Pharmaceuticals
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Tucson, Arizona (5.4 mi)
· Sponsor: Sameek Roychowdhury
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
The University of Arizona Cancer Center - North Campus — Tucson, Arizona (5.4 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients (MOTION-P)
Knee Osteoarthritis
Phase 3
Interventional 300 participants sought
Tucson Orthopaedic Institute — Tucson, Arizona (5.4 mi)
· Sponsor: Doron Therapeutics Inc.
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Del Sol Research Management, LLC — Tucson, Arizona (5.4 mi)
· Sponsor: Ardelyx
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: Children's Oncology Group
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Advanced Cancer
Phase 1
Interventional 164 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: Riboscience, LLC.
EXtubation Related Complications - the EXTUBE Study (EXTUBE)
Extubation
N/A
Observational 3,000 participants sought
Banner University Medical Centre — Tucson, Arizona (5.4 mi)
· Sponsor: University Health Network, Toronto
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
University of Arizona Cancer Center ( Site 0035) — Tucson, Arizona (5.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 410 participants sought
The University of Arizona Cancer Center — Tucson, Arizona (5.4 mi)
· Sponsor: AVEO Pharmaceuticals, Inc.
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Locally Advanced Cervical Cancer
Phase 3
Interventional 800 participants sought
Research Site — Tucson, Arizona (5.4 mi)
· Sponsor: AstraZeneca
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
Tucson Cystic Fibrosis Center — Tucson, Arizona (5.4 mi)
· Sponsor: Nicole Hamblett
First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
Solid Tumor
Phase 1, Phase 2
Interventional 156 participants sought
SCRI - Arizona Oncology Associates — Tucson, Arizona (5.4 mi)
· Sponsor: Corbus Pharmaceuticals Inc.
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
SLE, SLE (Systemic Lupus)
Phase 1
Interventional 24 participants sought
AARA Clinical Research — Tucson, Arizona (5.4 mi)
· Sponsor: Cullinan Therapeutics Inc.
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Phase 3
Interventional 450 participants sought
Local Institution - 0205 — Tucson, Arizona (5.4 mi)
· Sponsor: Bristol-Myers Squibb
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction
N/A
Interventional 750 participants sought
Banner - University Medical Center Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: Pulnovo Medical, Inc.
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Tucson, Arizona (5.4 mi)
· Sponsor: Axsome Therapeutics, Inc.
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
University of Arizona Cancer Center-Orange Grove Campus — Tucson, Arizona (5.4 mi)
· Sponsor: SWOG Cancer Research Network
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
University of Arizona Cancer Center-Orange Grove Campus — Tucson, Arizona (5.4 mi)
· Sponsor: SWOG Cancer Research Network
High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)
Breast Cancer
N/A
Interventional 600 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
Enhancing Language Function in Aphasia
Aphasia, Acquired, Language Disorders
N/A
Interventional 30 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Adobe Clinical Research — Tucson, Arizona (5.4 mi)
· Sponsor: Regeneron Pharmaceuticals
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
Hemorrhagic Shock, Trauma Injury
Phase 3
Interventional 1,000 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: Philip Spinella